Skip to content

Author

P. Cogswell

We have 3 of 132 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy.

Neuroimaging is now a cornerstone of Alzheimer's disease care and a crucial discriminator tool for characterising brain injury across the lifespan and with emerging fluid biomarkers, neuroimaging supports accurate diagnosis, prognosis, and treatment monitoring.

Tammie L. S. Benzinger, P. Cogswell, A. Arani et al. · 2 citations
#artificial intelligence Open access Sep 2026

Artificial Intelligence-Based Detection of ARIA on MRI During Alzheimer Disease Therapy: Expert Opinion on Responsible Clinical Integration.

Amyloid-targeted monoclonal antibody therapies have introduced a new era in the treatment of early Alzheimer disease. However, their use has increased the importance of detecting and monitoring amyloid-related imaging abnormalities (ARIA) on MRI, as such findings may influence treatment continuation, dose modification,...

J. Petrella, F. Barkhof, T. Benzinger et al. · 0 citations
Open access Jul 2026

Diffusion MRI identifies a prolonged Pre-WMH Phase in Cerebral Small Vessel Disease

Diffusion MRI biomarkers were abnormal at least a decade before WMH abnormality in the population, revealing a prolonged phase of early SVD and highlighting their potential for SVD prevention.

P. Vemuri, Ming-Zhao Hu, Emily S. Lundt et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.